<SEC-DOCUMENT>0001193125-21-268828.txt : 20210909
<SEC-HEADER>0001193125-21-268828.hdr.sgml : 20210909
<ACCEPTANCE-DATETIME>20210909161421
ACCESSION NUMBER:		0001193125-21-268828
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210909
DATE AS OF CHANGE:		20210909

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QuantumScape Corp
		CENTRAL INDEX KEY:			0001811414
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				850796578
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-251433
		FILM NUMBER:		211244561

	BUSINESS ADDRESS:	
		STREET 1:		1730 TECHNOLOGY DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95110
		BUSINESS PHONE:		(408) 452-2000

	MAIL ADDRESS:	
		STREET 1:		1730 TECHNOLOGY DRIVE
		CITY:			SAN JOSE
		STATE:			CA
		ZIP:			95110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kensington Capital Acquisition Corp.
		DATE OF NAME CHANGE:	20200505
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>d205679d424b3.htm
<DESCRIPTION>424B3
<TEXT>
<HTML><HEAD>
<TITLE>424B3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 424(b)(3)</B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-251433</FONT></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PROSPECTUS SUPPLEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(To Prospectus dated
May&nbsp;18, 2021) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>306,053,642 Shares of Class&nbsp;A Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>6,650,000 Warrants </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g205679snap1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement supplements the prospectus dated May&nbsp;18, 2021 (as supplemented to date, the
&#147;Prospectus&#148;), which forms a part of our Registration Statement on Post-Effective Amendment No.&nbsp;3 to the Form <FONT STYLE="white-space:nowrap">S-1</FONT> (Registration Statement <FONT STYLE="white-space:nowrap">No.&nbsp;333-</FONT>
251433) filed with the Securities and Exchange Commission (the &#147;Commission&#148;) on May&nbsp;17, 2021 and declared effective by the Commission on May&nbsp;18, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Prospectus and this Prospectus Supplement relate to the disposition from time to time of 1) up to 306,053,642 shares of our Class&nbsp;A
Common Stock, which include Class&nbsp;A Common Stock issuable upon conversion of our Class&nbsp;B Common Stock, the exercise of certain private placement and public warrants (together, the &#147;Warrants&#148;), the exercise of certain stock
options, and the vesting of certain restricted stock units, and 2) up to 6,650,000 private placement warrants, which are held or may be held by the selling securityholders named in the Prospectus. We will not receive any proceeds from the sale of
our securities offered by the selling securityholders under the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On August&nbsp;24, 2021, we redeemed all outstanding public
warrants that had not been exercised as of such date (the &#147;Redemption Date&#148;). We have received an aggregate of $151,430,588.87 from the cash exercise of public warrants prior to the Redemption Date, net of the amount paid for redemption of
unexercised public warrants. We expect to receive approximately $53,582,122.50 assuming the exercise of all outstanding private placement warrants for cash at a current exercise price of $11.50 per share, less the amount that will not be received
due to cashless exercises and redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement should be read in conjunction with the Prospectus, which is to be
delivered with this Prospectus Supplement. This Prospectus Supplement updates, amends and supplements the information included or incorporated by reference in the Prospectus. If there is any inconsistency between the information in the Prospectus
and this Prospectus Supplement, you should rely on the information in this Prospectus Supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Prospectus Supplement is not
complete without, and may not be delivered or utilized except in connection with, the Prospectus, including any amendments or supplements to it. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;8, 2021, we filed a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> with the Commission. The portion of
the text of such Form <FONT STYLE="white-space:nowrap">8-K</FONT> that is treated as &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended, is attached hereto. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Investing in our securities involves a high degree of risk. In reviewing the Prospectus
and this Prospectus Supplement, you should carefully consider the matters described under the heading &#147;</B><B><I>Risk Factors</I></B><B>&#148; beginning on page 6 of the Prospectus. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>You should rely only on the information contained in the Prospectus, this Prospectus Supplement or any Prospectus Supplement or amendment
hereto. We have not authorized anyone to provide you with different information. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The date of this prospectus supplement is September&nbsp;8, 2021. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM 8-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant
to Section 13 or 15(d) </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of report (Date of earliest event reported): September 7, 2021 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>QuantumScape Corporation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact Name of Registrant as Specified in Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>001-39345</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>85-0796578</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1730 Technology Drive</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>San Jose, California</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>95110</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(Address of principal executive offices)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Zip code)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(408) 452-2000 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name or former address, if changed since last report) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title of each class</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Trading</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Symbol(s)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name of each exchange</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>on which registered</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Class A common stock, par value $0.0001 per share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>QS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>The New York Stock Exchange</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (&#167; 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company &#9746; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;8.01. Other Events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Extraordinary Performance Award Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;7, 2021, the board of directors of QuantumScape Corporation (the &#147;Company&#148;) approved an &#147;Extraordinary
Performance Award Program&#148; (the &#147;EPA Program&#148;). This EPA Program will only become effective if approved by the stockholders (excluding shares held by interested parties) at the Company&#146;s annual stockholder meeting expected to be
held in November (the &#147;Annual Meeting&#148;). The EPA Program provides performance-based equity incentives linked to significant long-term stockholder value creation. A summary overview of the EPA Program is below, and the EPA Program will be
described in more detail in the proxy statement to be delivered to stockholders in advance of the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Purpose </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A primary purpose of the EPA Program is to incent senior management by granting equity rewards that are tied to achieving both exceptional
stock performance and significant business milestones over a nine-year period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The EPA Program also seeks to encourage the Company to
seek large-scale deployment of the Company&#146;s technology over the next nine years. The Company is conscious that the world&#146;s climate crisis requires major and rapid reductions in carbon emissions and that the Company&#146;s solid-state
battery may contribute to society&#146;s transition away from fossil fuels. Accordingly, the business milestones emphasize production and sales growth. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Performance-based Stock Options </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The EPA
Program provides stock option grants to the Company&#146;s Chief Executive Officer, Jagdeep Singh, and other members of the Company&#146;s management team that are earned over five tranches if the Company meets
<FONT STYLE="white-space:nowrap">pre-defined</FONT> stock price targets and business milestones. Each of the five tranches requires that the Company achieve <U>both</U> the next stock price target <U>and</U> one of the business milestones listed
below within nine years of the initial grants. Participants generally have to remain with the Company for one year after the date a tranche is met in order to vest in the stock options earned with that tranche. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, the first tranche of the EPA Program cannot be met unless the Company achieves at least one of the business milestones <U>and</U>
the Company&#146;s stock price increases to $60, which would be approximately a 171% increase from the closing price on September&nbsp;7, 2021 of $22.18. Similarly, the fifth tranche cannot be met unless the Company has met at least five of the
business milestones (including the business milestones used to satisfy each of the four earlier tranches) <U>and</U> the Company&#146;s stock price increases to $480, which would be approximately a 2,064% increase from the closing price on
September&nbsp;7, 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stock price targets are $60, $120, $240, $360 and $480. Assuming a beginning stock price of $26 (based on a <FONT
STYLE="white-space:nowrap">30-day</FONT> average for July 2021) and approximately 415&nbsp;million shares outstanding as of June&nbsp;30, 2021, these stock price targets correspond approximately to market capitalizations of $25&nbsp;billion,
$50&nbsp;billion, $100&nbsp;billion, $150&nbsp;billion, and $200&nbsp;billion, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each tranche requires completion of a
business milestone that was not used to satisfy a prior tranche. The business milestones are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Automotive original equipment manufacturer validation of a completed B sample battery cell (a B sample is a
functional, complete battery cell prototype that may be built with pilot tools). </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delivery of at least 1 GWh of battery cells to a single customer. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Delivery of at least 1 GWh of battery cells to each of three or more customers. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$5&nbsp;billion in revenue over a period of trailing four quarters. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">$10&nbsp;billion in revenue over a period of trailing four quarters. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Total cumulative production of 500 GWh. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Total cumulative production of 1,000 GWh. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Adjusted EBITDA margin of 25% over four consecutive quarters. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">10% of worldwide market share in automotive battery cells, excluding China. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(x)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">20% of worldwide market share in automotive battery cells, excluding China. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To permit flexibility in how the business develops, the production, sales and market share
targets are independent of the Company&#146;s business model and include cells manufactured by the Company, its subsidiaries, joint ventures and licensees, and by cell makers who incorporate separators manufactured by or under license from the
Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Sharing Ratio; Participants </U></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Stock option grants under the EPA Program may total up to 4% of the total shares outstanding as of September&nbsp;7, 2021, which means that
gains in stock price would primarily benefit the stockholders. For example, based on the closing price on September&nbsp;7, 2021, if the Company meets the requirements for the first tranche, participants in the EPA Program would realize
approximately 0.79% of the total increase in stockholder value, and the stockholders would realize approximately 99.21% of the total increase in stockholder value. If the Company meets the requirements of all five tranches, participants in the EPA
Program would realize approximately 3.98% of the total increase in stockholder value and the stockholders would realize approximately 96.02% of the total increase in stockholder value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Participants </U></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The EPA Program provides
that Mr.&nbsp;Singh, the Company&#146;s Chief Executive Officer, would be granted a stock option for <FONT STYLE="white-space:nowrap">one-half</FONT> of the shares subject to the EPA Program. A condition of the award to Mr.&nbsp;Singh is that he
would not be eligible to receive any other equity awards from the Company for seven years. We believe this ties Mr.&nbsp;Singh&#146;s long-term incentives to significant stockholder value creation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The remaining options under the EPA Program would be shared by at least 14 other members of the Company, including other executive officers
and employees who are key contributors to the Company&#146;s research and development efforts, manufacturing, and business operations. Participants other than Mr.&nbsp;Singh would be eligible for additional equity grants consistent with standard
practice. All stock options under the EPA Program would be granted under the Company&#146;s 2020 Equity Incentive Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain information in this Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> may be considered &#147;forward-looking
statements,&#148; within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, including, without limitation, statements regarding future timeline, stock
price, product development, production, revenue, market share, and financial results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The stock price and business milestones described
above are intentionally ambitious and there are significant risks and uncertainties in achieving such results. Many of the obstacles to achieving the business milestones are described in the &#147;Risk Factors&#148; section in the Company&#146;s
Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the Securities and Exchange Commission (the &#147;SEC&#148;) on July&nbsp;29, 2021 and available at&nbsp;www.sec.gov. Such risks and uncertainties include, but are not
limited to the below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company faces significant barriers in its attempts to produce a solid-state battery cell and may not be able
to successfully develop its solid-state battery cell. Building high volumes of multi-layer cells in commercially relevant sizes and with higher layer count requires substantial development effort. The Company could encounter significant delays
and/or technical challenges in replicating the performance seen in its single-layer cells and four-layer cells and in achieving the high quality, consistency and throughput required for commercial production and sale. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company may encounter delays and cost overruns related to planning, permitting, construction, equipment
installation, utilities infrastructure installation and operations <FONT STYLE="white-space:nowrap">start-up</FONT> of our manufacturing facilities, and other obstacles including vendor delays and challenges in operating new manufacturing equipment
for automated and/or continuous flow processes and optimizing complex manufacturing processes. Even if the Company successfully develops the capability for high volume production, the product may not succeed in the market due to competition or other
factors. Furthermore, even if the Company achieves volume production and the product succeeds in the market, it will be extremely challenging to establish production (directly and through joint ventures and licensing) to meet the volume and market
share milestones within nine years. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Company&#146;s stock price depends on market conditions and other factors unrelated to the Company, so even
if the business milestones are met for the EPA Program, the stock price targets may not be met. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise
required by applicable law, the Company disclaims any duty to update any forward-looking statements to reflect events or circumstances after the date of this report. Should underlying assumptions prove incorrect, actual results and projections could
different materially from those expressed in any forward-looking statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, hereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: September&nbsp;9, 2021 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="5" NOWRAP><B>QUANTUMSCAPE CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" NOWRAP>By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael McCarthy</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Name: Michael McCarthy</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" NOWRAP>&nbsp;&nbsp;&nbsp;&nbsp;Title: Chief Legal Officer and Head of Corporate Development</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g205679snap1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g205679snap1.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @,# @(# @(" P0# P,#! 0$ @,$! 0$! ,$! ,! @(" @(" @(" @,"
M @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# __$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /W\H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M690\-S9WEK(\-S;NA#+)&[*P.02* +U !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % 'R+^V]XT\3^%?@'J_A[P).UK\0/B_XC\*_!'P/<
MH\D3VFN?$S5HM!GOHY8@9(9K307UFZCE3!CDM4DR-F0 >X?![X5^%O@E\,_!
MOPM\&6B6F@>#=%M=*MV$:QS:A=(OFZGK-]LX?4M2U*2ZOKA_XIKN0C P ;?(
M-OD>E4 % !0 4 % !0 4 % '->+O!GA+Q_X?O_"GC?PWHGBSPWJD1AO]$\0:
M;:ZKIMRA5E#/:WD3H)4W$I*H5XVPR,K $ 'Y\7G[+/QD_9=U"]\8?L5>*6U3
MP6]Q/J7B#]EGXCZO<WO@_4Q)*);G_A7'BF^F>Y\'ZRR[_+2YE,4K[3<7,D<:
M6S&P;'TW\ _VG? GQW75]"M[/6/ 7Q3\(LMOX]^#_CBV.D>.?"=VNQ9)38SJ
MG]LZ$SNGDZK9*\+K-#YH@EE$0 /I&@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * /E/]I+2UU+QM^R/Y\7FV-A^TO8:A.K$"-;FT^$7Q;FT
MJ1E/#,FII:NG<.BD<BC] _0^K* "@ H * "@ H * "@ H * "@#YT^.?[-7@
MOXUOH_B1;[5/A_\ %KP>_P!J\ ?&'P8R6'C/PM>)N:.VGE4K'XD\-2LSI=:'
MJ7FVL\4\Z*(7E,H-O*P;>5CE_A)\<?%^G^+;;X$_M&:;IOA?XP&WN)/!OBS2
M$D@^'GQTT?3HM]SKG@BXG_Y!?BJVMU$NJ^%+AA=6N3=6@FL7W6Y^@?H?6= !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!XO\ '3P_=:MX3T+6
M]-L;O4=6^'OQ!\!_$'3[*QADN+RYA\/>(;1/$%O:P1*TDT\WA*^\0PI'&K,[
M3!5!+4;>5@V\K'M% !0 4 % !0 4 % !0 4 % !0 4 >=_%#X6^#?B_X3N?!
M_C6PEN+)KBVU+2M3T^ZETSQ%X6\0Z=)Y^C>*O">N6N+G0/$NFW86>UOK9E9&
M4HXDAEEBD/T#]#S;X4>-O&?AW7A\$_C1>0W_ (ZL+*YO? ?Q"BMHM/TKXT^$
M-,\I)]7CM(0(-'^(FDQRVR>(-!BPF98M5TX-I]VT>GGZ!^A]&T % !0 4 %
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M #[7\*>)]&\:>&= \7>';K[9H7B72-/UO2;HQO"\MAJ-M'=6YF@E DMKA8Y
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M<]AI6@Z;;V#Q>(-4UVQ\/O*7N[BZNXHK"#3W*KITDTUQ$LD*R@'T_P#L6_\
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MNGO3F9KB0W)D\T[Z-O(-O(_#+_@C%9V>G?'/]HK3]/G^U6%AX5L;.QN=ZO\
M:+.U\87$%M/O3Y7\R%$?<O!W9'% &%\"? W@[QW_ ,%>?BY:>,["PU6U\/\
MCSXN^*M$TO4HH[BSO/$FC7C_ -EO):S I<2V2W-SJ42L"%ETN*3'[J@#[Q_X
M*^^"/!^M?LH7WC'5[&P7Q7X*\7>$V\):LT,2ZFO]MZM'I&KZ/!=8$K6-QIMW
M<7<EMN*,^EPRE=T"D'Z!^A\9>-_&WC"3_@BU\/R]S>+_ &AXBL?!%_<@S+))
MX/T?XE>(TTNV>0G(LU&A:/8@ A&BB6+E6P0#B/V)OCK^U?\ !WX&Z3I?P._8
MRC^(7AC7=3UO5KWXD6NF^(Y[KQE?IJEY8.]]=Z=((IETQ+;^RHXEPD:Z>WRB
M225G-@V.G_9,^&?[3NE_M]Z/\;-5_9J\4?!?P5XZU#Q5!XUTNPT'5+'P9HMC
MKGA:]EO );O'V>TN/%=E8:BL+8CCN9$2)51(U4V\@V\C^C&@ H * /Q+_:N_
MX)=>);[X@S_';]D'Q-#X!\</J<OB"]\&+JESX7A@U^5VDN-7\!^([#:- GN9
M))GDTVY\FU#32F&Y@A86P-O(-O(^;/%EI_P6(\;>#-9^"WC+P3JOBCPWX@L9
M-!UF35_#WP<OQJ.G287;-XH<^1O5TCFCO_/6ZCEBCE2=945@ ?+?B+]D#XU?
ML3Z_\*_CA\;_ (2>'OB5\.M.\06.H>)O#FF:U+K&DZ;<V]P1:Z)XQN]/M_)L
M)I7,-Q;3?Z?I=Q/"EK</,)'MIC;Y!M\C^CWPM\0/@G^W=^SWXMTWPAX@-]X6
M\=^&-1\)>)].'DV_BGP3J.K:=)&+75]+:1_L.K64Q2YMW)DMK@VJ2V\LT!#D
M _&[P)\%_P#@J#^Q+<^+?AW\$?#MIXY\"^(=5FU*QU;2;7PSXET*6_,26$?B
M&QT[6K^"_P##6K2V-O9)<6][$;9C:Q!A<K"DI-@V/L'_ ()V_L/?%7X2^/?&
M?[1_[15Y$WQ5\:V>JVMCH']HVNLZE82>)M1@UCQ-XC\2ZGITLEDVNWUQ"D,=
MM9RSI#%-=F23?,L5N;!L<1^W1^PQ\;;CXX6'[6?[)D[GQ^MQINI^(?#MA?:=
MI>NVOB+1[.+3(?$WATZM)'I^J6U[I4$5OJ&EW#!I625O+NTOYHH#] _0\(^*
M/P1_X*@?MA_#S4(/C'H]CX=T/P2EOJOAGX>0_P#")^%]0\?>+3=6NF1W5Q9P
M:KY47V'2[[5+LW.JW=I;QK#)'8VSS719#] _0^[/@M^SQ\7O"?\ P34\6? #
M7O"@L?BQJ7@/XQZ-9>%_[9T.X$VH^*=5\37.@VYU>VU"33H_M,&H6C;VN@D?
MFXD92K8-@V-+_@EW^S_\6?V=?@QXZ\*?%_PN/"FO:Q\3+OQ!IMB-7T76?M&D
M2>%_#6G)=&?0]0O(8LWFGW<?EO(K_NMQ7:RDFP;'@WA_]DSX^6/_  5'N_VB
MKGP.(O@_+XI\0ZBGBO\ X2'PTQ-E??"J_P##EK,-&35CJ>7UF>*WV&S##<7(
M$8W4 =-_P5(_9 ^+_P >+CX8_%'X*:>OB/Q)\/K34M'U7PQ%?6&GZM+93ZA:
M:MI6LZ&^IW$%M=SVE['>+/;&5966:W:%)-DB@_0/T/IO]C7Q]^V-\0+/QB?V
MK_A?X>^']EIMAX=L/",EA9Q6&I>);YQJR>)[S5M.7Q+JGDQB*/2"H2WL("US
M.(D91MB/T#]#\Q-6_9%_;>_8F^-/C'QU^R#IT/COP!XQ>[@@L8%T74YH-#N+
MY]0T_0/%/AG6KRUGEO-*F<QV^J::[[XU9VD@^U3VU&P;'I7[+7[%W[3OQ._:
M;T_]K3]L(IH>H^'M2M->T;PY<3Z.^M:QK6DVIM/#$*:5H,DMEX9\-Z,R6]RD
M4DBW4LMG"K0GSY[B@#T7_@J1^RK\=OVBO%OP2U/X/>"1XKLO"&E^*[?7YCK_
M (<T7[!-J6I^';BR0IKNJV;SB2*QN6S LH7ROFP2H8 ^N/V]/A'\0/C/^R;X
MR^&?PWT(>(/&FJ7'@5['1SJ.F:7YR:-XJT+4M1/V[5;NVM4,5G9W$F'F7=Y>
MU<LP! +7[ 'PG\>_!+]E?P%\./B7H8\.^,=%O_&<VHZ2-0TW5/L\6J^+];U3
M3V^VZ3=W-K(9;&[MY,1S-M\S:V&4@&P;'Q1_P37_ &/?C+\%O%GQ^'QW^'=M
MH_A7XC>%K#P_:VUUKGAK7K37;634]:&K:?<6VBZM=NEO)IU\%<3I$&68J,G(
M!L&QXAXC_8M_;9_8M^)OB+QC^Q5K%YXO^'?B24%M!CNM!O=5M[!7GDM-'\6^
M%?%#QVNO26!FEBM=7TWS;DI(SD6C32(YL&Q5T3]C+]M_]M7XI>&?&'[9E]<>
M#/A[X8E"_P!E7$V@6&HOI1FMIM0T7P?X4\,RR1Z/=:D8(H[C5M3\J95C63-V
M;:&&C] _0_3']M[]BK0_VI_A%H7A/P[<Z;X2\;?#?=/\--2N(9!H]M;-9VUC
M>>%=3%O')-;Z'>VMCIX\Z".22VFTVTE"2HDL,Y^@?H?FQI,G_!9#P5X2M/@/
MI'A.:YLM/M(?#6C?$)&\#ZAJUAHD*_9+46OCJYUM8$@ALU5([R_MVU"*-$Q(
MLJ)@V^0;?(^X_P!K']C?XB_M9?LR_#?2O&6H^%;#]I7X=:3;ZHNI:?-<GPEK
M6NW>FVUIXK\/R7LEHLMG::JUE8W*W*VYCAO;")0/LCN]'Z!^A\,^!?"G_!7?
M5O"-I^S/=63^#/!45@G@^\^)/B%_"+W^B>#E46$EM:^,=.U&ZO=4MHM,)@AD
ML(+G4?*"1QSQ[0\9MY6#;RL>\_\ !,?]D+XW_LT?%3XRZC\3?"3:+X9UKP[9
MZ'X6UI]9\.7[ZU_9_B2::*9K#1=8O9K!I=/6.X*3J@7S0F2P(!L&Q^?-S\-O
MBY\1_P#@HW^T<OP&\41>$_B[X'\:_$OQ_P""KNXFBMK;4[W1/$=K8WF@S7-Q
M');0B_TW5[N';>QO9S#-M=[8+AY(P#V;XA?!'_@I_P#MKZYX8^'WQP\/VW@+
MP+X>U:.]O;^[C\,Z'X3L;M5>RG\12V&AZK=7OB[5X[*>[2UBMC+"OGR+&UK'
M<2S$_0/T/VDU?]E+X;:O^RZO[*4JW4?@:#P39>$[/4PD#ZM:ZEIKPZA9>+55
ME\HZTOB.!-7=<+%),TB$"*0K0!^.7@/X4?\ !47]B.77OAS\'/#FF?%'X<:A
MJ=U?Z-<VT&B^(] 2ZN/W3:MI^FZAJ]AJ_A>^GBC@>YLY\V9E4L//.9I#8-C]
M(OV'?#'[<6FMXW\3_M:^+M*N-/\ %5R=3\/>!9QI6I>(_#FJ3R0--+!J/AZ7
M^S- \."S0PQZ'"]]B3]\#:.)A?FP;'Z#T % !0 4 % &=JVD:5KVEZAHFN:;
M8ZQHVJ6D]AJ>E:G:07VG:A8W,;0W-G>V=RCQ7-M+$S(\<B,K D$$4 ?B5\:?
MV"/C)^S+XZN_VAOV!-=U2S>.5KGQ'\&?/:],^F^8+BZTS1+2]D:+Q=X==E8_
MV'?L;Z [6TZXFF$*6QM\@V^1]*_LJ_\ !2[X7?&ZXM_ 'Q3@B^"WQIM[AM+O
M/#?B*2:P\.:UJMNP@F@T#5=4\M].U%KA70Z+JIAND?$,,EZRLX/T#]#],: "
M@ H * "@ H * "@ H Y3QIXLL_!6@3ZW=6\U],;O3=*TG2;5HUO=:UW6]0MM
M)T71[+S6"_:+K4;NWBW'Y8T+ROB.)R #J_T_I0 4 % !0 4 % !0 4 % !0
M4 ?@!^R=!.G_  5Q_:1F:"986F^-(65HI%C.?%.A8VNR@$$ XP>>U '[_P!
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< "@ H * "@ H * "@ H * "@ H * "@ H __V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
